Critical assessment of pharmaceutical processes--A rationale for changing the synthetic route.
Butters
Mike
M
AstraZeneca, Process R&D, Avlon/Charnwood, Avlon Works, Severn Road, Hallen, Bristol BS10 7ZE, UK. Mike.Butters@astrazeneca.com
Catterick
David
D
Craig
Andrew
A
Curzons
Alan
A
Dale
David
D
Gillmore
Adam
A
Green
Stuart P
SP
Marziano
Ivan
I
Sherlock
Jon-Paul
JP
White
Wesley
W
D002626:Chemistry, Pharmaceutical / Q000331:legislation & jurisprudence / Q000379:methods / Q000592:standards; D064420:Drug-Related Side Effects and Adverse Reactions; D007880:Legislation, Drug; D004364:Pharmaceutical Preparations / Q000138:chemical synthesis* / Q000737:chemistry; D012449:Safety
D004364:Pharmaceutical Preparations